thyssenkrupp nucera AG & Co. KGaA Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 16, 2025
thyssenkrupp-nucera-ag-&-co.-kgaa-beat-analyst-estimates:-see-what-the-consensus-is-forecasting-for-this-year

thyssenkrupp nucera AG & Co. KGaA (ETR:NCH2) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. thyssenkrupp nucera KGaA delivered a significant beat to revenue and earnings per share (EPS) expectations, hitting €262m-13% above indicated-and€0.07-250% above forecasts- respectively Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

View our latest analysis for thyssenkrupp nucera KGaA

earnings-and-revenue-growth

XTRA:NCH2 Earnings and Revenue Growth February 16th 2025

After the latest results, the consensus from thyssenkrupp nucera KGaA’s twelve analysts is for revenues of €892.4m in 2025, which would reflect a measurable 2.8% decline in revenue compared to the last year of performance. Statutory earnings per share are expected to crater 45% to €0.078 in the same period. Before this earnings report, the analysts had been forecasting revenues of €892.7m and earnings per share (EPS) of €0.06 in 2025. Although the revenue estimates have not really changed, we can see there’s been a sizeable expansion in earnings per share expectations, suggesting that the analysts have become more bullish after the latest result.

The consensus price target was unchanged at €13.88, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company’s valuation. There are some variant perceptions on thyssenkrupp nucera KGaA, with the most bullish analyst valuing it at €22.00 and the most bearish at €8.40 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that revenue is expected to reverse, with a forecast 3.7% annualised decline to the end of 2025. That is a notable change from historical growth of 29% over the last year. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 4.5% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining – thyssenkrupp nucera KGaA is expected to lag the wider industry.

Leave a comment